Grants and Publications
Individualized Dosing of Therapeutic Monoclonal Antibodies—a Changing Treatment Paradigm?
Identification of Peptide Mimotope Ligands for Natalizumab
A phase I study of escalated dose subcutaneous alemtuzumab given weekly with rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma
A general process for the development of peptide-based immunoassays for monoclonal antibodies